The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).

Learn more

ACRS key data

Previous close2.64 USD

Market cap290.37M USD

Volume495.75K

P/E ratio-

Dividend yield (TTM)0.00%

Dividend amount-

Last ex-dividend date-

Last payment date-

EPS diluted (TTM)-1.38 USD

Net income (FY)−132.06M USD

Revenue (FY)18.72M USD

Next report dateNov 5, 2025

EPS estimate-0.140 USD

Revenue estimate1.30M USD

Shares float92.30M

Beta (1Y)2.10

Have you heard of tokenized stocks?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Aclaris Therapeutics, Inc. overview

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Sector

Health technology

Industry

Pharmaceuticals: Major

CEO

Neal S. Walker

Headquarters

Wayne

Website

aclaristx.com

Founded

2012

Employees (FY)

Change (1Y)

−27 −29.67%

Revenue / Employee (1Y)

292.50K USD

Net income / Employee (1Y)

−2.06M USD

ACRS competitors

Name	Market cap	Price	Change %	P/E ratio	EPS diluted (TTM)	Dividend yield (TTM)
Incyte Corporation INCY	20.46BUSD	104.24USD	+0.78%	17.49	5.961 USD	0.00%
United Therapeutics Corporation UTHR	20.46BUSD	475.27USD	-0.33%	18.01	26.385 USD	0.00%
West Pharmaceutical Services, Inc. WST	19.59BUSD	272.35USD	+0.19%	40.34	6.751 USD	0.31%
Illumina, Inc. ILMN	22.04BUSD	144.22USD	-1.88%	32.31	4.463 USD	0.00%
Zimmer Biomet Holdings, Inc. ZBH	17.20BUSD	86.77USD	-1.78%	21.47	4.041 USD	1.09%
Hologic, Inc. HOLX	16.73BUSD	75.02USD	+0.19%	30.21	2.483 USD	0.00%

All stocks

Trending tokenized stocks

NVDAon

NVIDIA Tokenized Stock (Ondo)

$181.91

-1.40%

TSLAon

Tesla Tokenized Stock (Ondo)

$439.68

-1.95%

GOOGLon

Alphabet Class A Tokenized Stock (Ondo)

$332.71

-1.86%

SPYon

SPDR S&P 500 Tokenized ETF (Ondo)

$692.28

-0.70%

PLTRon

Palantir Technologies Tokenized Stock (Ondo)

$176.02

-1.57%

AAPLon

Apple Tokenized Stock (Ondo)

$259.81

-0.18%

More tokenized stocks

Trending cryptos

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Aclaris Therapeutics, Inc.?

ACRS is currently priced at 2.64 USD — its price has changed by -1.49% over the past 24 hours. You can track the stock price performance of Aclaris Therapeutics, Inc. more closely on the price chart at the top of this page.

What is the stock ticker of Aclaris Therapeutics, Inc.?

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ, Aclaris Therapeutics, Inc. is traded under the ticker ACRS.

What is the stock forecast of ACRS?

We've gathered analysts' opinions on Aclaris Therapeutics, Inc.'s future price. According to their forecasts, ACRS has a maximum estimate of 26.40 USD and a minimum estimate of 5.28 USD.

What is the market cap of Aclaris Therapeutics, Inc.?

Aclaris Therapeutics, Inc. has a market capitalization of 290.37M USD.

Home/

Stocks/

NASDAQ/

ACRS